Concepedia
Cancer · 2005 · 109 citations · 21 references
Open access
CapGem is an active and well tolerated first-line combination chemotherapy regimen for patients with advanced/metastatic biliary tract carcinoma that offers a convenient home-based therapy.
21
Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
Masanori Miwa, Masako Ura, M Nishida et al. · European Journal of Cancer · 1998 · 1.2K citations
Medicinal Chemistry, Cancer Tissue, Medicine +8
One-Sample Multiple Testing Procedure for Phase II Clinical Trials
Thomas R. Fleming · Biometrics · 1982 · 993 citations
Surgical Oncology, Clinical Endpoint, Metronomic Chemotherapy +17
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials
Eric Van Cutsem, Paulo M. Hoff, Peter Harper et al. · British Journal of Cancer · 2004 · 396 citations · Full text
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study
Thierry André, Christophe Tournigand, Olivier Rosmorduc et al. · Annals of Oncology · 2004 · 381 citations
Gastrointestinal Oncology, Medicine, Biliary Cancer +6
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.
Melanie Mackean, André Planting, Chris Twelves et al. · Journal of Clinical Oncology · 1998 · 266 citations